
Keywords: اداره غذا و داروی ایالات متحده; pediatric cardiology; pediatric pulmonary; pulmonary hypertension; BPD; bronchopulmonary dysplasia; CDH; congenital diaphragmatic hernia; FDA; US Food and Drug Administration; NT-proBNP; N-terminal pro-brain-type natriuretic peptide; PAH; pulmonary arteri